A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity
- PMID: 6863909
- PMCID: PMC2134273
- DOI: 10.1017/s0022172400028989
A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity
Abstract
Groups of volunteers were immunized subcutaneously with one of three inactivated influenza virus A/USSR/77 (H1N1) vaccine preparations; a whole virus vaccine, a surface-antigen subunit adsorbed vaccine, or an aqueous surface-antigen subunit vaccine. The reactions to immunization were recorded, and the antibody response was measured 1 month later. A fourth group of volunteers were inoculated intranasally with live attentuated A/USSR/77 (H1N1) influenza virus; the reactions and antibody response of these volunteers were also measured. One month after immunization, the incidence of infection by challenge with homologous live attentuated virus was determined for all groups of volunteers. The results showed that all four vaccines used were relatively non-reactogenic, and that inactivated vaccines induced higher titres of serum antibody than the live attenuated vaccine. All the vaccines induced significant protection against challenge virus infection which was directly related to the level of serum HI antibody response.
Similar articles
-
A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity.J Hyg (Lond). 1983 Jun;90(3):361-70. doi: 10.1017/s0022172400028990. J Hyg (Lond). 1983. PMID: 6863910 Free PMC article.
-
A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection.J Hyg (Lond). 1984 Jun;92(3):263-76. doi: 10.1017/s0022172400064500. J Hyg (Lond). 1984. PMID: 6736638 Free PMC article.
-
E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1).Acta Virol. 1982 Dec;26(6):466-73. Acta Virol. 1982. PMID: 6132540
-
Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?Jpn J Infect Dis. 2016;69(3):165-79. doi: 10.7883/yoken.JJID.2015.560. Jpn J Infect Dis. 2016. PMID: 27212584 Review.
-
Influenza vaccine immunology.Immunol Rev. 2011 Jan;239(1):167-77. doi: 10.1111/j.1600-065X.2010.00974.x. Immunol Rev. 2011. PMID: 21198671 Review.
Cited by
-
A new approach to estimate vaccine efficacy based on immunogenicity data applied to influenza vaccines administered by the intradermal or intramuscular routes.Hum Vaccin. 2010 Oct;6(10):841-8. doi: 10.4161/hv.6.10.12636. Epub 2010 Oct 1. Hum Vaccin. 2010. PMID: 20930559 Free PMC article.
-
Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model.BMC Med Res Methodol. 2010 Mar 8;10:18. doi: 10.1186/1471-2288-10-18. BMC Med Res Methodol. 2010. PMID: 20210985 Free PMC article.
-
A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity.J Hyg (Lond). 1983 Jun;90(3):361-70. doi: 10.1017/s0022172400028990. J Hyg (Lond). 1983. PMID: 6863910 Free PMC article.
-
Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles.J Virol. 2000 Jan;74(1):371-8. doi: 10.1128/jvi.74.1.371-378.2000. J Virol. 2000. PMID: 10590126 Free PMC article.
-
Interpretation of responses and protective levels of antibody against attenuated influenza A viruses using single radial haemolysis.J Hyg (Lond). 1984 Oct;93(2):301-12. doi: 10.1017/s0022172400064834. J Hyg (Lond). 1984. PMID: 6389697 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical